Literature DB >> 17020581

Formation of active inclusion bodies in the periplasm of Escherichia coli.

Jean-Philippe Arié1, Marika Miot, Nathalie Sassoon, Jean-Michel Betton.   

Abstract

To examine the relationship between folding and aggregation in the periplasm of Escherichia coli, we have analysed the cellular fates of exported proteins fused to either the wild-type maltose-binding protein (MalE) or the aggregation-prone variant MalE31. The propensity of fusion proteins to aggregate in the periplasm was determined by the intrinsic folding characteristics of the upstream protein. When beta-lactamase or alkaline phosphatase was linked to the C-terminus of MalE31, the resultant fusion proteins accumulated in an insoluble form, but retained their catalytic activity. In addition, these protein aggregates induced an extracytoplasmic stress response, similar to unfused MalE31. However, using a fluorescent substrate, we found that alkaline phosphatase activity was present inside periplasmic aggregates. These results suggest that periplasmic inclusion body formation may result in intermolecular interactions between participating proteins without loss of function of the fused enzymes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17020581     DOI: 10.1111/j.1365-2958.2006.05394.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  19 in total

1.  A rapid protein folding assay for the bacterial periplasm.

Authors:  Thomas J Mansell; Stephen W Linderman; Adam C Fisher; Matthew P DeLisa
Journal:  Protein Sci       Date:  2010-05       Impact factor: 6.725

Review 2.  Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies.

Authors:  Sudhir Sahdev; Sunil K Khattar; Kulvinder Singh Saini
Journal:  Mol Cell Biochem       Date:  2007-09-12       Impact factor: 3.396

Review 3.  Protein folding and aggregation in bacteria.

Authors:  Raimon Sabate; Natalia S de Groot; Salvador Ventura
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

4.  Combinatorial mutagenesis and selection of improved signal sequences and their application for high-level production of translocated heterologous proteins in Escherichia coli.

Authors:  Tonje Marita Bjerkan Heggeset; Veronika Kucharova; Ingemar Naerdal; Svein Valla; Håvard Sletta; Trond Erling Ellingsen; Trygve Brautaset
Journal:  Appl Environ Microbiol       Date:  2012-11-09       Impact factor: 4.792

5.  Components of the E. coli envelope are affected by and can react to protein over-production in the cytoplasm.

Authors:  Riccardo Villa; Marina Lotti; Pietro Gatti-Lafranconi
Journal:  Microb Cell Fact       Date:  2009-06-05       Impact factor: 5.328

6.  Influence of production process design on inclusion bodies protein: the case of an Antarctic flavohemoglobin.

Authors:  Ermenegilda Parrilli; Maria Giuliani; Gennaro Marino; Maria Luisa Tutino
Journal:  Microb Cell Fact       Date:  2010-03-24       Impact factor: 5.328

7.  Isolation of cell-free bacterial inclusion bodies.

Authors:  Escarlata Rodríguez-Carmona; Olivia Cano-Garrido; Joaquin Seras-Franzoso; Antonio Villaverde; Elena García-Fruitós
Journal:  Microb Cell Fact       Date:  2010-09-17       Impact factor: 5.328

8.  Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli.

Authors:  Wei Wu; Lei Xing; Bihong Zhou; Zhanglin Lin
Journal:  Microb Cell Fact       Date:  2011-02-15       Impact factor: 5.328

9.  Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2009-05-14       Impact factor: 5.328

10.  Active inclusion bodies of acid phosphatase PhoC: aggregation induced by GFP fusion and activities modulated by linker flexibility.

Authors:  Ziliang Huang; Chong Zhang; Shuo Chen; Fengchun Ye; Xin-Hui Xing
Journal:  Microb Cell Fact       Date:  2013-03-14       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.